Our Team
We are led by an accomplished team with an exceptional track record of discovering, developing, and commercializing meaningful therapies for patients while creating value for stockholders. Our founding team has deep knowledge and significant experience in cGMP pathway research and development.

Andy Busch, PhD
Chief Scientific Officer

Mark Currie, PhD
Chair of Scientific Adivsory Board

Christopher Wright, MD, PhD
Chief Medical Officer

Cheryl Gault
Chief Operating Officer

Peter Hecht, PhD
Chief Executive Officer

Daryn Lewis
Vice President, Head of People

William Huyett
Strategic Advisor

Anjeza Gjino
Chief Financial Officer

Andy Busch, PhD
Chief Scientific Officer
Mark Currie, PhD
Chair of Scientific Adivsory Board
Christopher Wright, MD, PhD
Chief Medical Officer
Cheryl Gault
Chief Operating Officer
Peter Hecht, PhD
Chief Executive Officer
Daryn Lewis
Vice President, Head of People
William Huyett
Strategic Advisor
Anjeza Gjino
Chief Financial Officer
Our Scientific Advisors
The women and men on our advisory boards bring diverse, global perspectives from basic science, clinical practice and industry to help us create better medicines for CNS disorders.
Robert C. Malenka, MD, PhD: Pritzker Professor of Psychiatry and Behavioral Sciences, Director of the Nancy Pritzker Laboratory, and Deputy Director of the Wu Tsai Neurosciences Institute at Stanford University
Daniela Salvemini, PhD: Professor of Pharmacology and Physiology and Director of the Henry and Amelia Nasrallah Center for Neuroscience at St. Louis University
Harald H.H.W. Schmidt, MD, PhD, PharmD: Professor of Pharmacology and Chairman of the Department of Pharmacology and Personalized Medicine at Maastricht University
Eric Smith, MD: Professor of Neurology and the Katthy Taylor Chair in Vascular Dementia at the University of Calgary, Calgary Stroke Program
M Brandon Westover, MD, PhD: Physician Investigator in Neurology at Mass General Research Institute, Associate Professor of Neurology at Harvard Medical School, Associate Neurologist in Neurology at Massachusetts General Hospital, and Co-Founder, Beacon Biosignals